Published in Health and Medicine Week, October 27th, 2003
Claims in the patent describe a method of treating diseases resulting from degradation of nitric oxide and accumulation of peroxynitrite by administration of a catalytic-antioxidant compound.
A prominent theory of amyotrophic lateral sclerosis (ALS) is that accumulation of peroxynitrite plays a causative role in the destruction of motor neurons.
"This patent confers additional new protection for our priority project of developing a drug for treatment of ALS," stated Richard E. Gammans, PhD, Incara's head of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.